Organ in Medical Technology
Navigation Links
Organ in Medical Technology
... immune system is compromised -- as after solid organ transplantation -- CMV can cause serious illness ... lengths to safeguard the health of the organ and patient post-transplant. We already ... important serious infection complicating solid organ transplantation. Transplant patients may already ...
... A hand transplant, unlike a solid organ transplant, involves multiple tissues (skin, ... for the next three months. Kentucky organ Donor Affiliates (KODA) worked very closely with the Indiana organ Procurement Organization to coordinate the hand ...
... in adult patients at risk for organ rejection or infection subsequent to kidney ... role of the ImmuKnow assay in monitoring risk for organ rejection. The mean ATP level of the three patients who underwent acute organ rejection was 247 +/- 193 ng/mL. "We are ...
... range post-transplant, showed no evidence of organ rejection. Several patients showed evidence of ... undergoing immunosuppressive therapy for organ transplantation by measuring the concentration ... immune function in immune-suppressed organ transplant patient populations. The ImmuKnow ...
... transplantation and graft rejection after solid organ transplantation), serious bacterial and ... hematopoietic stem cell (bone marrow) or solid organ transplantation are at high risk of CMV ... but prior to the completion of the Phase 3 solid organ clinical trial will be successful as the ...
... promise and potential of our Autologous organ Regeneration Platform as a foundation for our ... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ... address the most critical problems facing organ and tissue failure patients, enabling people to ...
... is associated with the failure of one or more organ systems, such as cardiovascular or respiratory," ... pathways that contribute to sepsis-induced organ damage and associated morbidity and mortality." ... days, shock-free days, incidence and severity of organ failure/dysfunction and circulating levels of ...
... transplantation. In addition, strategies for organ preservation during transport from donor to ... aiming to maintain, and possibly improve, donor organ function once they have been removed from the donor." NON-HEART-BEATING DONORS organ transplantation is currently limited by a ...
... an increase of 0.30 points or more from baseline); and (3) no new BILAG A organ domain score (which indicates a severe flare of lupus disease activity) and no more than one new BILAG B organ domain score (which would indicate a moderate flare of disease activity). ...
... therapy tailored to treat the gastrointestinal manifestation of GVHD, the organ system where GVHD is most frequently encountered and highly problematic. ... cancer patients after receiving hematopoietic cell transplantation. Unlike organ transplants where the patient's body may reject the organ, in GVHD it is ...
... is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two ...
... surveillance together with ImmuKnow can be useful to prevent infection or organ rejection by tailoring immunosuppressive therapy." For each patient, viral ... in an immunosuppressed population, and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's ...
... Overall, the frequencies of adverse events by MedDRA System organ Class in both cladribine treatment groups were comparable to those ... of the study. Observed malignancies were isolated cases across different organ systems. The current ongoing clinical studies with Cladribine Tablets will ...
... to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants. (Logo: ... in an immunosuppressed population, and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... and commercializing human neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses biocompatible materials and a ... candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives ...
... inflammatory response syndrome (SIRS)/capillary leak syndrome, and organ dysfunction. Clolar should be discontinued immediately in the event of ... prior to and during treatment with Clolar, as the liver is a target organ for Clolar toxicity and Clolar is excreted primarily through the kidneys. ...
... is approved under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal ...
... of an unbalanced immune system that can become destructive to any major organ or tissue in the body. Lupus is unpredictable and potentially fatal, yet ... consequences may include heart attacks, strokes, seizures, or sudden organ failure. Current treatments are immune-suppressing agents, which have ...
Fifth U.S. Hand Transplant Patient Heads Home to NY
... tests." A hand transplant, unlike a solid organ transplant, involves multiple tissues (skin, ... 32 patients around the world. Kentuckiana organ Donor Affiliates (KODA) worked very closely with the Indiana organ Procurement Organization to coordinate the hand ...ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
... defined as symptomatic CMV infection or CMV organ disease, occurred during the study drug ... disease (either symptomatic CMV infection or CMV organ disease) within 6 months post transplantation, ... hematopoietic stem cell (bone marrow) or solid organ transplantation are at high risk of CMV ....... A hand transplant, unlike a solid organ transplant, involves multiple tissues (skin, ... for the next three months. Kentucky organ Donor Affiliates (KODA) worked very closely with the Indiana organ Procurement Organization to coordinate the hand ...
Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
... assess the value of the assay predicting risk for organ rejection, in predicting risk for infection, ... with a goal of optimizing survival and minimizing organ rejection. Patients will have blood drawn ... undergoing immunosuppressive therapy for organ transplantation by measuring the concentration of ...... in adult patients at risk for organ rejection or infection subsequent to kidney ... role of the ImmuKnow assay in monitoring risk for organ rejection. The mean ATP level of the three patients who underwent acute organ rejection was 247 +/- 193 ng/mL. "We are ...
... range post-transplant, showed no evidence of organ rejection. Several patients showed evidence of ... undergoing immunosuppressive therapy for organ transplantation by measuring the concentration ... immune function in immune-suppressed organ transplant patient populations. The ImmuKnow ...
... transplantation and graft rejection after solid organ transplantation), serious bacterial and ... hematopoietic stem cell (bone marrow) or solid organ transplantation are at high risk of CMV ... but prior to the completion of the Phase 3 solid organ clinical trial will be successful as the ...
... promise and potential of our Autologous organ Regeneration Platform as a foundation for our ... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ... address the most critical problems facing organ and tissue failure patients, enabling people to ...
... is associated with the failure of one or more organ systems, such as cardiovascular or respiratory," ... pathways that contribute to sepsis-induced organ damage and associated morbidity and mortality." ... days, shock-free days, incidence and severity of organ failure/dysfunction and circulating levels of ...
... transplantation. In addition, strategies for organ preservation during transport from donor to ... aiming to maintain, and possibly improve, donor organ function once they have been removed from the donor." NON-HEART-BEATING DONORS organ transplantation is currently limited by a ...
Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
... In the United States, the United Network for organ Sharing (UNOS) oversees the allocation of donor ... center no longer provides an advantage for organ allocation. However, it is unclear whether it ... study suggest that even though the current donor organ allocation system favors the most critically-ill ...Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
... of patients worldwide who would benefit from an organ transplant and the number of organs available, a ... market research report from Kalorama Information, organ Transplant Immunosuppressive Markets. In the ... Roche's CellCept have reduced incidence of acute organ rejection and made transplantation a viable ...Northwestern Memorial Transplant Program Initiates New Study
... transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can ... Northwestern Memorial Hospital's department of organ transplantation to enroll qualifying subjects in ... and an HLA compatibility test is performed before organ transplantation to find out if tissues match ...Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
... of current treatment options for patients with organ and tissue failure or loss," said ... company, has pioneered the Autologous organ Regeneration Platform(TM) that catalyzes the ... the potential to cure -- rather than treat - - organ and tissue failure, enabling people to ...Allegheny General Hospital Performs First Liver Transplant
... 1, represents a milestone locally in the field of organ transplantation, providing end stage liver ... at AGH and for the availability of the donor organ that saved her life. "I am alive today because ... the gift of life that was bestowed to me from an organ donor and their family. My children still have a ...Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
... a paradigm shift in the way physicians will deliver drugs to all organ systems in the future. "The implantation of this kind of device on any organ and the ability to deliver medication to the affected organ, could be a ...First Potential Lupus-Specific Treatment in Sight
... is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two ...... an increase of 0.30 points or more from baseline); and (3) no new BILAG A organ domain score (which indicates a severe flare of lupus disease activity) and no more than one new BILAG B organ domain score (which would indicate a moderate flare of disease activity). ...
... therapy tailored to treat the gastrointestinal manifestation of GVHD, the organ system where GVHD is most frequently encountered and highly problematic. ... cancer patients after receiving hematopoietic cell transplantation. Unlike organ transplants where the patient's body may reject the organ, in GVHD it is ...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... on the Pancreas Transplantation Committee for the United Network for organ Sharing. He was also the Medical Director of the New Jersey organ and Tissue Sharing Network. In 2005, he received the National Medical ...... is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two ...
... surveillance together with ImmuKnow can be useful to prevent infection or organ rejection by tailoring immunosuppressive therapy." For each patient, viral ... in an immunosuppressed population, and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's ...
... Overall, the frequencies of adverse events by MedDRA System organ Class in both cladribine treatment groups were comparable to those ... of the study. Observed malignancies were isolated cases across different organ systems. The current ongoing clinical studies with Cladribine Tablets will ...
... to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants. (Logo: ... in an immunosuppressed population, and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's ...
Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
... an incision made in the patient's belly button to help guide surgeons. The organ is then surgically resected and taken out the vagina. "Millions of ... care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics. Northwestern Memorial ...... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
... sub-cellular level in a less invasive manner than treating disease at the organ or systemic level." While OmegaGenesis is initially focusing its ... level in a non-intrusive manner instead of treating disease at the organ or tissue level. Our mission emphasized collaborative research in ...... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
... New St. Jude treatment alleviates long-term anemia and organ damage in mice and paves the way for human applications MEMPHIS, ... Persons, the paper's senior author. "The mice showed no anemia, and their organ function was essentially normal." The researchers also ...... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... and commercializing human neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses biocompatible materials and a ... candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives ...
... inflammatory response syndrome (SIRS)/capillary leak syndrome, and organ dysfunction. Clolar should be discontinued immediately in the event of ... prior to and during treatment with Clolar, as the liver is a target organ for Clolar toxicity and Clolar is excreted primarily through the kidneys. ...
... is approved under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and ...
... is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first ... and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal ...
... of an unbalanced immune system that can become destructive to any major organ or tissue in the body. Lupus is unpredictable and potentially fatal, yet ... consequences may include heart attacks, strokes, seizures, or sudden organ failure. Current treatments are immune-suppressing agents, which have ...
Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
... swelling, pain, loss of function and may ultimately destroy the involved organ if left untreated. Current therapies for lupus treat the symptoms of the ... drugs (NSAIDS), corticosteroids, and, in severe cases where organ damage is at risk, immunosuppressant drugs. About Rigel ( ...Other ContentsvirologyvirologyvirologyclassificationclassificationclassificationclassificationclassificationclassificationevolutionevolutionevolutionevolutionevolutionevolutionvirusvirusvirusvirusvirusvirusvirusvirusvirusspectrumspectrumspectrumspectrumspectrumspectrumspectrumspectrumspectrumopticalopticalopticalopticalopticalopticalopticalopticalopticalvisionvisionvisionvisionvisionvisionvisionvisionvitaminvitaminvitaminvitaminvitaminvitaminvitaminvitaminOther TagsHurHurHurOther Tagsexperiencing 2experiencing 3experiencing 4experiencing 5experiencing 6experiencing 7experiencing 8experiencing 9experiencing 10parallel 2parallel 3parallel 4parallel 5appetite 2
(Date:11/26/2009)...logists have at last worked out a way of using rec... of bird populations. This is the first time sound...slated into accurate estimates of bird species, po...the British Ecological Society,s Journal of Appli...uld lead to a major advance in our ability to moni...
(Date:11/25/2009)...ADENA, Calif.Scientists at the California Institut...of a primitive emotion-like behavior in the fruit ..., which may be relevant to the relationship betwee...cit hyperactivity disorder (ADHD), are described i...The Drosophila brain contains only about 20,000 ...
(Date:11/25/2009)...ISON, WI, NOVEMBER 25, 2009 Soil is the linchpin ...nd hydrosphere meet. Despite that, many students s...t nothing more. Soil science educators are challen...ic recognize the critical importance of soil in th...l science and earth science teachers at University...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2The Doctor Will See You Now Online 62045 1The Doctor Will See You Now Online 62045 2US Patent Allowed for NOD Tech 14964 1Biolaxy Secures IND Approval for Oral Insulin 14962 1Biolaxy Secures IND Approval for Oral Insulin 14962 2(Date:11/30/2009)... 30 At a briefing of th... and the Consortium for Citizens with Disabilities...lic Policy and Advocacy for NCOA, called on Congre...esponds to the growing crisis in long-term care fo...ons of seniors, after working hard all their lives...
(Date:11/30/2009)...emic is far from over. Every year, almost three m...llion die from AIDS-related diseases." ,, WASH...d AIDS Day 2009 the Global AIDS Alliance (GAA) cal...on two recent alarming reports from the World Heal...ic continues to be of catastrophic proportion, aff...
(Date:11/30/2009)...ng significant impact, CBO analysis understates th...Newswire/ -- The Blue Cross and Blue Shield Asso...arding the estimate released today by the Congress...firmed what many economists, actuaries, and health...althcare reform bill would make coverage more expe...
(Date:11/30/2009)...as equivalent to 113 chest X-rays, study finds , ...e than half of patients who have abdominal/pelvic ...sts that expose them to extra radiation, U.S. rese...nd pelvic series were performed on 500 patients ag... 30 to 50 years of age. The researchers concluded ...
(Date:11/30/2009).... 30 SEIU Local 21LA me...oration Sodexo will hold a rally Tuesday, Dec. 1, ... headquarters, 3800 Desire Parkway, New Orleans, t...ry disciplinary policies that target employees who...ber. Sodexo employees who clean schools in the Rec...
Breaking Medicine News(10 mins):Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2[0] NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions[0] GAA Calls on President Obama to Act on the Reality of AIDS[0] CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill[0] CT Scan Patients May Get Unnecessary Imaging[1] As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |